Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Shigella

In: Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 22.
Affiliations
Free Books & Documents
Review

Shigella

Thomas L. Hale et al.
Free Books & Documents

Excerpt

Gram-negative, facultative anaerobes of the genus Shigella are the principal agents of bacillary dysentery. This disease differs from profuse watery diarrhea, as is commonly seen in choleraic diarrhea or in enterotoxigenic Escherichia coli diarrhea, in that the dysenteric stool is scant and contains blood, mucus, and inflammatory cells. In some individuals suffering from shigellosis, however, moderate volume diarrhea is a prodrome or the sole manifestation of the infection. Bacillary dysentery constitutes a significant proportion of acute intestinal disease in the children of developing countries, and this infection is a major contributor to stunted growth of these children. Shigellosis also presents a significant risk to travelers from developed countries when visiting in endemic areas, and sporadic food or water-borne outbreaks occur in developed countries.

The pathogenic mechanism of shigellosis is complex, involving a possible enterotoxic and/or cytotoxic diarrheal prodrome, cytokine-mediated inflammation of the colon, and necrosis of the colonic epithelium. The underlying physiological insult that initiates this inflammatory cascade is the invasion of Shigella into the colonic epithelium and the lamina propria. The resulting colitis and ulceration of the mucosa result in bloody, mucoid stools, and/or febrile diarrhea.

PubMed Disclaimer

References

    1. Bennish ML, Salam MA, Khan WA et al. Treatment of shigellosis 3. Comparison of one-dose or 2-dose ciprofloxacin with standard 5-day therapy - a randomized, blinded trial. Ann Int Med. 1992;117:727. - PubMed
    1. Butler T, Speelman P, Kabir I et al. Colonic dysfunction during shigellosis. J Infect Dis. 1986;154:817. - PubMed
    1. Davis H, Taylor JP, Perdue JN et al. A shigellosis outbreak traced to commercially distributed shredded lettuce. Am J Epidemiol. 1988;128:1312. - PubMed
    1. Fasano A, Noriega FR, Maneval DR, et al: Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest 95:000, 1995. (in press) - PMC - PubMed
    1. Goldberg MB, Bârzu O, Parsot C. Unipolar localization and ATPase activity of IncA, a Shigella flexneri protein involved in intracellular movement. J Bacteriol. 1993;175:2189. - PMC - PubMed

LinkOut - more resources